Abstract:Abstract DICER1, an endoribonuclease required for microRNA (miRNA) biogenesis, is essential for embryogenesis and development of many organs including ovary. Germline truncating mutations in DICER1 are seen in families with the pleuropulmonary blastoma-family tumour and dysplasia syndrome. These individuals have a propensity to develop ovarian Sertoli-Leydig cell tumors (SLCTs), a rare class of sex-cord stromal cell tumors that occur in young female. We have recently identified hotspot somatic mutations in RNase IIIb domain (simplified as ‘hotspot mutations’ thereafter) of DICER1 in half of SLCTs. These hotspot mutations impaired IIIb cleavage activity of DICER1 in in vitro cleavage assay and caused a global abolishment of 5p-miRNAs and a partial reduction of 3p-miRNAs in mouse embryonic stems cells expressing ectopic mutant DICER1. However, whether the miRNA biogenesis defect occurs in tumor samples and how DICER1 hotspot mutations promote tumorigenesis are largely unknown. By reviewing the histological features of ovarian SLCTs, we observed a strong correlation between DICER1 hotspot mutation and ovairain SLCTs with retiform pattern, which is often malignant with worse prognosis. Using Illumina small RNA sequencing technology and Exiqon miRNA realtime qPCR, we reported that the global expression of 5p-miRNAs was dramatically reduced in ovarian SLCTs carrying DICER1 hotspot mutations compared to their counterparts without DICER1 hotspot mutation. Although the 3p-miRNAs were largely unaffected, a subset of 3p-miRNAs was significantly increased in ovarian SLCTs with DICER1 hotspot mutations. To address the impact of DICER1 mutation on cell fate, we examined the gene expression profile in SLCTs using Illumina DASL whole transcriptome analysis followed by validation with Nanostring nCounter system. The miRNA production defect was associated with deregulation of genes governing cell fate determination in ovary, such as CYP19A1 (aromatase), FOXL2, FST, FGF9 and FGFR2, and genes that are targets of let-7, such as HMGA2, DICER1, ARID3A and CDC25A. Accordingly, knockin of DICER1 hotspot mutation in SVOG3e cells (immortalized human granulosa cells) led to altered miRNA biogenesis and deregulated expression of genes crucial for ovarian gonadal genesis and cellular transformation. SVOG3e Cells expressing DICER1 hotspot mutation grew faster than those with wildtype DICER1, which was at least partially due to loss of let-7 expression because inhibition of let-7 function by a miRNA sponge also accelerated cell growth. Furthermore, we also showed that loss of function of RNase IIIa domain of DICER1 had similar effect on cell proliferation as wildtype DICER1. Taken together, our data revealed that the hotspot somatic mutations of DICER1 in RNase IIIb domain cause systemic loss of 5p-miRNAs and selective upregulation of some 3p-miRNAs to drive pseudo-differentiation of testicular elements in ovary and cause oncogenic transformation. Thus, our current study sheds lights on the oncogenic potential of DICER1 hotspot mutations in tumor development and sets the stage for developing effective treatment method for malignant ovarian SLCTs. Citation Format: Yemin Wang, Jiamin Chen, Winnie Yang, Janine Senz, Michael S. Anglesio, Blake Gilks, Gregg B. Morin, David G. Huntsman. The oncogenic role of DICER1 RNase IIIb domain mutations in ovarian sertoli-leydig cell tumors [abstract]. In: Proceedings of the 10th Biennial Ovarian Cancer Research Symposium; Sep 8-9, 2014; Seattle, WA. Philadelphia (PA): AACR; Clin Cancer Res 2015;21(16 Suppl):Abstract nr POSTER-BIOL-1349.

Abstract 5669: Rare germline variants on SI gene and the possibility of colorectal cancer development

Abstract 2927: MicroRNA Binding Site Polymorphisms Influence Ovarian Cancer Risk in the Collaborative Oncological Gene-Environment Study

Abstract 1562: Germline Polymorphisms in Cancer Stem Cell Genes Associate with Survival among Women with High-Grade Serous Ovarian Cancer

Abstract LB370: Exploring SLC35B family genes in colorectal carcinoma: Bioinformatics and functional insights into prognosis and therapy

Abstract 2206: Genetic Variants in Selenoprotein Genes and Risk of Esophageal Squamous Cell Carcinoma and Gastric Cancer in a Chinese Population

Abstract 1773: Deciphering the roles of germline predisposition variants and somatic mutations on breast cancer cells and the tumor microenvironment

Prevalence and Spectrum Analysis of Germline DICER1 Variants of Solid Tumors: Decoding the Mysterious Signals of the Genome.

Abstract 1448: Unraveling the oncogenic pathway of serrated polyposis syndrome driven by RNF43 germline mutation

Abstract 5873: Distinct Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Between Early-Onset and Late-Onset Colorectal Caner

Abstract 4622: Common Genetic Variants in Epigenetic Machinery Genes and Risk of Upper Gastrointestinal Cancers

Association between germline variants and somatic mutations in colorectal cancer

Abstract 5777: Germline Variants of Cancer Predisposition Genes in a Large Cohort of Chinese Sarcoma Patients

Abstract 7336: Exploring the impact of cancer predisposition gene variants by functional analysis and whole genome sequencing analysis in hereditary cancer patients

Abstract POSTER-BIOL-1349: The oncogenic role of DICER1 RNase IIIb domain mutations in ovarian sertoli-leydig cell tumors

Abstract 6155: Germline variants in cancer susceptibility genes and subsequent neoplasm risks after childhood cancer: A pooled analysis of two large-scale cohorts

The effect of genetic variants of SLC22A18 on proliferation, migration, and invasion of colon cancer cells

Abstract 6463: Highly frequent gene mutations and co-occurring genes analysis in colorectal cancer

Abstract 2632: Genetic Variants of Iron-Dependent Metabolism Genes and Risk of Upper Gastrointestinal Cancers

Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer

SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer

Abstract PS8-29: Rare Variants in the Germline Genome Holistically Determine Receptor-Independent Her2 Signaling Pathway Activation and Immune Suppression, Shaping Pathological Type and Risk of HER2-negative Breast Cancer